{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:10:11Z","timestamp":1768518611965,"version":"3.49.0"},"posted":{"date-parts":[[2025,2,23]]},"group-title":"Microbiology","reference-count":60,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:00:00Z","timestamp":1740268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,2,23]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>\n                  Assessing antibody titers and functional responses is essential for evaluating vaccine efficacy, yet the impact of blood collection methods on these immunological assessments remains unclear. Retro-orbital (RO) blood collection is commonly used but significant complications can occur. Increasingly, investigators have adopted alternative blood collection approaches, such as saphenous vein (SV) sampling to improve laboratory animal welfare. This study compared RO and SV sampling in the development of a\n                  <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                  (Ng) vaccine, evaluating Adhesin Complex Protein (ACP) and multiple transferable resistance (Mtr) E protein (MtrE) as antigen candidates. Epitope mapping revealed that ACP and MtrE possess multiple, highly accessible B-cell and T-cell epitope clusters, reinforcing their immunological potential. Following intranasal immunization with rACP, rACP+CpG, and rMtrE+CpG, we assessed the specificity, magnitude, kinetics, and functional quality of immune responses elicited by the immunization regimens. Out of 45 comparisons, only eight significant differences were detected in antibody titers, while the human serum bactericidal assays revealed no differences between RO and SV in antigen-immunized groups. However, antibodies elicited by rACP alone or ACP+CpG in SV samples restored 30.05% and 75.2% of human lysozyme hydrolytic activity compared to 19.3 and 59.9 % in RO, respectively suggesting that SV sampling may be more reliable for assessing functional antibody responses. Beyond its immunological advantages, SV sampling reduces stress, minimizes ocular trauma, and improves animal welfare, making it a viable alternative to RO collection. Given its widespread use in vaccine research, standardizing SV sampling could improve data reliability, ethical compliance, and translational relevance in preclinical studies.\n                <\/jats:p>","DOI":"10.1101\/2025.02.23.639724","type":"posted-content","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T21:45:12Z","timestamp":1740347112000},"source":"Crossref","is-referenced-by-count":0,"title":["Bridging Gaps in Antibody Responses and Animal Welfare: Assessing Blood Collection Methods and Vaginal Immunity in Mice Immunized with Intranasal Gonococcal Vaccines"],"prefix":"10.64898","author":[{"given":"Abhishek","family":"Chanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junaid","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Sargent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7977-2596","authenticated-orcid":false,"given":"Aleksandra E.","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"3","key":"2025022512250585000_2025.02.23.639724v1.1","first-page":"317","article-title":"Type, duration, and incidence of pathologic findings after retroorbital bleeding of mice by experienced and novice personnel","volume":"54","year":"2015","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"2025022512250585000_2025.02.23.639724v1.2","doi-asserted-by":"publisher","DOI":"10.1186\/s42826-021-00090-4"},{"key":"2025022512250585000_2025.02.23.639724v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/laban.738"},{"key":"2025022512250585000_2025.02.23.639724v1.4","doi-asserted-by":"publisher","DOI":"10.1258\/002367792780809048"},{"key":"2025022512250585000_2025.02.23.639724v1.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238895"},{"key":"2025022512250585000_2025.02.23.639724v1.6","doi-asserted-by":"publisher","DOI":"10.1258\/002367798780599866"},{"issue":"3","key":"2025022512250585000_2025.02.23.639724v1.7","first-page":"e23","article-title":"Molecular basis of host specificity in human pathogenic bacteria","volume":"3","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"2025022512250585000_2025.02.23.639724v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2017.169"},{"key":"2025022512250585000_2025.02.23.639724v1.9","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00094-23"},{"key":"2025022512250585000_2025.02.23.639724v1.10","unstructured":"Prevention, C.f.D.C.a. Sexually Transmitted Infections Surveillance, 2022. 2024."},{"key":"2025022512250585000_2025.02.23.639724v1.11","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7312a2"},{"key":"2025022512250585000_2025.02.23.639724v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.06.001"},{"key":"2025022512250585000_2025.02.23.639724v1.13","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2249124"},{"key":"2025022512250585000_2025.02.23.639724v1.14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007080"},{"key":"2025022512250585000_2025.02.23.639724v1.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006448"},{"key":"2025022512250585000_2025.02.23.639724v1.16","doi-asserted-by":"crossref","unstructured":"Hung, M.C. , J.E. Heckels , and M. Christodoulides , The adhesin complex protein (ACP) of Neisseria meningitidis is a new adhesin with vaccine potential. MBio, 2013. 4(2).","DOI":"10.1128\/mBio.00041-13"},{"key":"2025022512250585000_2025.02.23.639724v1.17","doi-asserted-by":"crossref","unstructured":"Baarda, B.I. , et al., Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates. mSphere, 2021. 6(1).","DOI":"10.1128\/mSphere.00977-20"},{"key":"2025022512250585000_2025.02.23.639724v1.18","doi-asserted-by":"crossref","unstructured":"Almonacid-Mendoza, H.L. , et al., Structure of the Recombinant Neisseria gonorrhoeae Adhesin Complex Protein (rNg-ACP) and Generation of Murine Antibodies with Bactericidal Activity against Gonococci. mSphere, 2018. 3(5).","DOI":"10.1128\/mSphere.00331-18"},{"key":"2025022512250585000_2025.02.23.639724v1.19","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00245-23"},{"key":"2025022512250585000_2025.02.23.639724v1.20","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-143-7-2127"},{"key":"2025022512250585000_2025.02.23.639724v1.21","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00010-14"},{"key":"2025022512250585000_2025.02.23.639724v1.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097475"},{"key":"2025022512250585000_2025.02.23.639724v1.23","doi-asserted-by":"crossref","unstructured":"Ayala, J.C. , J.T. Balthazar , and W.M. Shafer , Transcriptional regulation of the mtrCDE efflux pump operon: importance for Neisseria gonorrhoeae antimicrobial resistance. Microbiology (Reading), 2022. 168(8).","DOI":"10.1099\/mic.0.001231"},{"key":"2025022512250585000_2025.02.23.639724v1.24","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.10.5576-5582.2003"},{"key":"2025022512250585000_2025.02.23.639724v1.25","doi-asserted-by":"publisher","DOI":"10.1086\/522964"},{"key":"2025022512250585000_2025.02.23.639724v1.26","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02688"},{"key":"2025022512250585000_2025.02.23.639724v1.27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012578"},{"key":"2025022512250585000_2025.02.23.639724v1.28","doi-asserted-by":"crossref","unstructured":"Stover, E.L. , et al., Development and validation of multiplex assays for mouse and human IgG and IgA to Neisseria gonorrhoeae antigens. J Infect Dis, 2024.","DOI":"10.1093\/infdis\/jiae153"},{"key":"2025022512250585000_2025.02.23.639724v1.29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007081"},{"key":"2025022512250585000_2025.02.23.639724v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2015.10.008"},{"key":"2025022512250585000_2025.02.23.639724v1.31","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2019.1701185"},{"key":"2025022512250585000_2025.02.23.639724v1.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00479-7"},{"key":"2025022512250585000_2025.02.23.639724v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.10.077"},{"key":"2025022512250585000_2025.02.23.639724v1.34","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00388-22"},{"key":"2025022512250585000_2025.02.23.639724v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.05.011"},{"key":"2025022512250585000_2025.02.23.639724v1.36","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.1.314-322.1993"},{"key":"2025022512250585000_2025.02.23.639724v1.37","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.4.1272-1283.1996"},{"key":"2025022512250585000_2025.02.23.639724v1.38","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.2.514-520.1998"},{"key":"2025022512250585000_2025.02.23.639724v1.39","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.7.3390-3396.1998"},{"key":"2025022512250585000_2025.02.23.639724v1.40","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.6.2884-2890.1999"},{"key":"2025022512250585000_2025.02.23.639724v1.41","doi-asserted-by":"publisher","DOI":"10.1086\/315801"},{"key":"2025022512250585000_2025.02.23.639724v1.42","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.7.3945-3953.2005"},{"key":"2025022512250585000_2025.02.23.639724v1.43","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.10.5539-5545.2000"},{"key":"2025022512250585000_2025.02.23.639724v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121180"},{"key":"2025022512250585000_2025.02.23.639724v1.45","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00124"},{"key":"2025022512250585000_2025.02.23.639724v1.46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003559"},{"key":"2025022512250585000_2025.02.23.639724v1.47","unstructured":"Amanda DeRocco , H.F.S., Greg Sempowski , Melissa Ventevogel , Ann E. Jerse , Development of MtrE, the outer membrane channel of the MtrCDE and FarAB,MtrE active efflux pump systems, as a gonorrhea vaccine. International Pathogenic Neisseria Conference, 2014."},{"key":"2025022512250585000_2025.02.23.639724v1.48","doi-asserted-by":"publisher","DOI":"10.1128\/mspheredirect.00069-18"},{"key":"2025022512250585000_2025.02.23.639724v1.49","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.11.7558-7568.2005"},{"key":"2025022512250585000_2025.02.23.639724v1.50","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000194222.93067.f7"},{"issue":"6","key":"2025022512250585000_2025.02.23.639724v1.51","first-page":"2259","article-title":"Nasal Administration of M2e\/CpG-ODN Encapsulated in N-Trimethyl Chitosan (TMC) Significantly Increases Specific Immune Responses in a Mouse Model","volume":"77","year":"2022","journal-title":"Arch Razi Inst"},{"key":"2025022512250585000_2025.02.23.639724v1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.003"},{"key":"2025022512250585000_2025.02.23.639724v1.53","doi-asserted-by":"crossref","unstructured":"Altay Benetti , A., et al., Design and Characterization of a New Formulation for the Delivery of COVID-19-mRNA Vaccine to the Nasal Mucosa. Vaccines (Basel), 2024. 12(4).","DOI":"10.3390\/vaccines12040409"},{"key":"2025022512250585000_2025.02.23.639724v1.54","doi-asserted-by":"crossref","unstructured":"Tai, J. , et al., Different Methods and Formulations of Drugs and Vaccines for Nasal Administration. Pharmaceutics, 2022. 14(5).","DOI":"10.3390\/pharmaceutics14051073"},{"key":"2025022512250585000_2025.02.23.639724v1.55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-514"},{"key":"2025022512250585000_2025.02.23.639724v1.56","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa379"},{"key":"2025022512250585000_2025.02.23.639724v1.57","unstructured":"DeLano, W.L. , PyMOL Molecular Graphics System. CCP4 Newsletter on protein crystallography, 2002. 40."},{"key":"2025022512250585000_2025.02.23.639724v1.58","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.3.532"},{"key":"2025022512250585000_2025.02.23.639724v1.59","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw288"},{"key":"2025022512250585000_2025.02.23.639724v1.60","doi-asserted-by":"publisher","DOI":"10.1002\/9780471729259.mc04a03s34"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.02.23.639724","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:06:45Z","timestamp":1768464405000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.02.23.639724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":60,"URL":"https:\/\/doi.org\/10.1101\/2025.02.23.639724","relation":{},"subject":[],"published":{"date-parts":[[2025,2,23]]},"subtype":"preprint"}}